Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (NYSE: EHAB), operating as Enhabit Home Health & Hospice, is a national home health and hospice provider whose activities generate a steady flow of company news and disclosures. As a public company listed on the New York Stock Exchange, Enhabit regularly issues press releases and files Form 8-K reports covering its financial results, strategic updates, leadership developments, and participation in investor conferences.
News about Enhabit often centers on quarterly earnings announcements, where the company reports net service revenue, segment performance for Home Health and Hospice, Adjusted EBITDA, and other financial and operational metrics. These releases highlight trends in home health and hospice admissions, average daily census, patient days, and segment-level profitability, as well as updates on branch openings, de novo locations, and changes in cost per patient day.
Investors following EHAB news will also see regular updates on guidance for net service revenue, Adjusted EBITDA, and Adjusted EPS, along with explanations of non-GAAP financial measures and same-store comparisons. Enhabit’s communications discuss how unusual or nonrecurring items affect its results and how management evaluates core operating performance.
Another key category of Enhabit news involves corporate and governance developments. The company has announced a CEO transition plan, retention awards for senior officers, approval of its 2025 Equity and Incentive Compensation Plan, and voting results from its annual meeting. In addition, Enhabit frequently reports on its participation in healthcare and home care conferences hosted by major financial institutions, where its leadership teams take part in fireside chats and presentations.
For readers tracking EHAB, this news flow provides insight into Enhabit’s home health and hospice operations, financial performance, capital structure, and governance decisions. Monitoring these updates can help contextualize the company’s strategic focus on patient care in the home and its reported progress across its nationwide footprint.
Enhabit (NYSE: EHAB)enterprise value of ~$1.1 billion. Stockholders will receive $13.80 per share in cash, a ~24.4% premium to the Feb 20, 2026 close. The deal is expected to close in Q2 2026, pending approvals; Enhabit will go private and continue operating under its brand.
Enhabit will not hold a Q4 2025 earnings call and will not issue 2026 guidance; Q4 and full‑year 2025 results are expected March 4, 2026 after market close.
Enhabit Home Health & Hospice (NYSE: EHAB) will report fourth-quarter and fiscal 2025 results on March 4, 2026 and host a webcast and conference call on March 5, 2026 at 9:00 a.m. EST.
Participants should join the webcast 15 minutes early. Call details: Toll-free 888-660-6150, International 929-203-0843, Conference ID 5248158. Webcast: https://events.q4inc.com/attendee/846254002. Enhabit operates 247 home health and 115 hospice locations across 34 states.
Enhabit (NYSE:EHAB) and Encompass Health (NYSE:EHC) collected $43.1 million in full satisfaction of claims for attorneys’ fees and mitigation damages from individual defendants in the Delaware Court of Chancery.
The December 2024 judgment found breaches of the duty of loyalty by named former officers; the court also placed a constructive trust granting Enhabit and Encompass Health a split of 43% of VitalCaring Group’s ongoing profits and exit proceeds if VitalCaring is sold. The settlement proceeds will be divided substantially equally between Enhabit and Encompass Health.
Enhabit (NYSE: EHAB) announced it will participate in the Bank of America Home Care Conference 2025. Enhabit President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will join a fireside chat on Tuesday, Dec. 9, 2025 at 2:50 p.m. CT.
The session will be webcast live at the provided Bank of America webcast URL, with a replay available within 24 hours. Both live and replay will also be accessible on Enhabit’s investor website under Events & Presentations.
Enhabit (NYSE: EHAB) reported Q3 2025 results for the quarter ended Sept. 30, 2025, with total net service revenue $263.6M, net income $11.1M, Adjusted EBITDA $27.0M, diluted EPS $0.22 and adjusted diluted EPS $0.17.
Key operational highlights: home health same-store admissions +3.6% and ADC +3.7% (Medicare ADC down 1.4%), hospice net service revenue +20.0% to $63.1M with hospice Adjusted EBITDA +72.0% and hospice ADC +12.6%. The company reduced bank debt by $15.0M in the quarter (7th straight quarter of prepayment) and reports a $100.0M reduction vs Q4 2023, yielding ~$19.2M annualized cash interest savings and a reported leverage of 3.9x.
Updated 2025 guidance: net service revenue $1,058–1,063M, Adjusted EBITDA $106–109M, Adjusted EPS $0.50–0.56.
Enhabit (NYSE: EHAB) will participate in the UBS Global Healthcare Conference 2025. Enhabit’s President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will appear in a fireside chat on Tuesday, Nov. 11, 2025 at 11:30 a.m. CT. The session will be webcast live and will be available for replay on Enhabit’s investor website.
Enhabit Home Health & Hospice (NYSE: EHAB) will report third-quarter 2025 results for the period ended Sept. 30, 2025 on Nov 5, 2025 and will host a webcast and conference call on Nov 6, 2025 at 9:00 a.m. ET.
Participants are asked to join 15 minutes early. Call numbers: Toll-free 888-660-6150, International 929-203-0843, Conference ID 5248158. Webcast: https://events.q4inc.com/attendee/991714917. A replay and webcast link will be available on Enhabit’s investor website.
Enhabit operates 249 home health locations and 114 hospice locations across 34 states. Investor contact: investorrelations@ehab.com.
Enhabit (NYSE:EHAB), a leading national home health and hospice provider, has announced its upcoming participation in the Jefferies 2025 Healthcare Services Conference. The company's President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in a fireside chat on Tuesday, September 30, 2025, at 10:55 a.m. CT. Investors can access the live webcast and replay through Enhabit's investor website.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, announced that President and CEO Barb Jacobsmeyer plans to step down from her roles in July 2026 or upon the appointment of a successor. The company has initiated a leadership succession plan and engaged Russell Reynolds Associates to conduct a comprehensive search for the next CEO.
As Enhabit's first CEO, Jacobsmeyer has played a crucial role in stabilizing the business and building momentum. The board has expressed commitment to ensuring a smooth transition while maintaining focus on executing the company's mission of providing high-quality, compassionate patient care.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, reported strong Q2 2025 results with net service revenue of $266.1 million and net income of $5.2 million. The company achieved notable growth metrics, including a 12.3% year-over-year increase in hospice average daily census and 1.3% growth in home health admissions.
Key financial highlights include Adjusted EBITDA of $26.9 million (up 6.7% YoY), earnings per share of $0.10, and adjusted diluted EPS of $0.13. The company strengthened its balance sheet by reducing bank debt by $10.0 million and has increased its full-year 2025 guidance, now projecting revenue between $1,060-$1,073 million and Adjusted EBITDA of $104-$108 million.